V Nikolayevskyy
Overview
Explore the profile of V Nikolayevskyy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anthony R, Tagliani E, Nikolayevskyy V, de Zwaan R, Mulder A, Kamst M, et al.
Microbiol Spectr
. 2022 Dec;
11(1):e0224422.
PMID: 36475728
Here, we report the development and key features of the first external quality assessment (EQA) scheme for Mycobacterium tuberculosis whole-genome sequencing (WGS). The results of four rounds (2017 to 2020)...
2.
Stieber F, Allen N, Carpenter K, Hu P, Alagna R, Rao S, et al.
Pulmonology
. 2022 Nov;
29(2):151-153.
PMID: 36402704
No abstract available.
3.
Klaos K, Holicka Y, Groenheit R, Kodmon C, van der Werf M, Nikolayevskyy V
Int J Tuberc Lung Dis
. 2021 Dec;
26(1):71-73.
PMID: 34969433
No abstract available.
4.
Stieber F, Howard J, Manissero D, Boyle J, Ndunda N, Love J, et al.
Int J Tuberc Lung Dis
. 2021 Oct;
25(11):917-922.
PMID: 34686234
Programmatic management of TB infection is a critical component of the WHO End TB Strategy. Interferon-gamma release assays (IGRAs) overcome some limitations of the tuberculin skin test, but implementation of...
5.
Folkvardsen D, Holicka Y, Kodmon C, van der Werf M, Lillebaek T, Nikolayevskyy V
Int J Tuberc Lung Dis
. 2021 Jan;
25(1):66-68.
PMID: 33384048
No abstract available.
6.
Nikolayevskyy V, Niemann S, Anthony R, van Soolingen D, Tagliani E, Kodmon C, et al.
Clin Microbiol Infect
. 2019 Apr;
25(11):1377-1382.
PMID: 30980928
Background: Tuberculosis (TB) remains a serious public health threat worldwide. Theoretically ultimate resolution of whole genome sequencing (WGS) for Mycobacterium tuberculosis complex (MTBC) strain classification makes this technology very attractive...
7.
Nikolayevskyy V, Kontsevaya I, Nikolaevskaya E, Surkova E, Samchenko S, Esipenko S
Clin Microbiol Infect
. 2018 Dec;
25(8):1040.e1-1040.e6.
PMID: 30590114
Objectives And Methods: The Xpert® MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) has been in routine use in Odessa Oblast, a region with the highest tuberculosis (TB) incidence in Ukraine, since...
8.
Southern J, Sridhar S, Tsou C, Hopkins S, Collier S, Nikolayevskyy V, et al.
Public Health
. 2018 Nov;
166:34-39.
PMID: 30439554
Objectives: This natural experiment was designed to assess the impact of exposure to an active case of tuberculosis (TB) on a group of immunosuppressed individuals, with end-stage renal disease over...
9.
Mathys V, Roycroft E, Raftery P, Groenheit R, Folkvardsen D, Homorodean D, et al.
Int J Tuberc Lung Dis
. 2018 Mar;
22(4):444-451.
PMID: 29562994
Setting: Implementation of novel diagnostic assays in tuberculosis (TB) laboratory diagnosis requires effective management of time and resources. Objective: To further develop and assess at multiple centres a time-and-motion (T&M)...
10.
Lange B, Khan P, Kalmambetova G, Al-Darraji H, Alland D, Antonenka U, et al.
Int J Tuberc Lung Dis
. 2017 Apr;
21(5):493-502.
PMID: 28399963
Setting: Xpert® MTB/RIF is the most widely used molecular assay for rapid diagnosis of tuberculosis (TB). The number of polymerase chain reaction cycles after which detectable product is generated (cycle...